9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
Clinical trial NCT06592326 · RECRUITING
Trial details
- NCT number
- NCT06592326
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-22
- Primary completion
- 2027-09-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.